Lilly to disclose fees paid to US doctors - update
This article was originally published in Scrip
Executive Summary
Lillywill begin disclosing the payments it makes to US doctors and other healthcare professionals who serve as advisors or speakers. Described as an industry first, the move comes ahead of the stalled bipartisan federal legislation, known as the Physicians Payments Sunshine Act. This would create a national registry of payments of more than $500 for services such as consulting, sitting on advisory boards, and research, along with gifts and travel. Progress of the bill is still far from certain.